Mexiletine hydrochloride

Mexiletine hydrochloride
Product Description

Active Pharmaceutical Ingredient. Arrhythmia indication. Cardiovascular therapeutic area.

AGC Pharma Chemicals Europe, S.L.U.

  • ES
  • 2020
    On CPHI since
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Specifications
  • CAS Registry Number
    226-362-1

AGC Pharma Chemicals Europe, S.L.U.

  • ES
  • 2020
    On CPHI since
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator

More Products from AGC Pharma Chemicals Europe, S.L.U. (4)

  • Telmisartan

    Product Telmisartan

    Active Pharmaceutical Ingredient. Hypertension indication. Cardiovascular therapeutic area.
  • Gliquidone

    Product Gliquidone

    Active Pharmaceutical Ingredient. Low blood sugar indication. Metabolic therapeutic area.
  • Dipyridamole

    Product Dipyridamole

    Active Pharmaceutical Ingredient. Stroke prevention indication. Cardiovascular therapeutic area.
  • Pirenzepine

    Product Pirenzepine

    Active Pharmaceutical Ingredient. Gastric ulcers indication. Gastrointestinal therapeutic area.

AGC Pharma Chemicals Europe, S.L.U. resources (2)

  • News AGC Pharma Chemicals to boost capacity by 30% at Spanish site

    The expansion will increase production capacity for synthetic pharmaceutical products
  • Video The first choice CDMO for small molecules API in Europe

    AGC Pharma Chemicals Europe is part of the Life Science Business of the AGC Group. It is located in Barcelona, Spain, and provides CDMO services, producing small molecules APIs, from kilo to commercial scale.
    AGC Pharma Chemicals Europe has one mission: to improve people's life by bringing our best quality products.
    We aim to be the first choice CDMO for customers by excelling our top pharma quality, development capability, supply reliability, and sustainability.
    Come and discover what AGC can do for you!